Health · CA ·
DNA changes in blood may signal cancer before diagnosis
News-Medical · Health
Published · Updated
- Researchers found early molecular signatures in blood plasma linked to future prostate and breast cancer.
- Prostate silencer methylation provided stronger risk stratification than breast enhancer signals.
- cfDNA methylation may be more valuable for risk assessment than as a standalone diagnostic test.
Read it at the source
News-Medical↗We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.
